Document is current
Any future updates will be listed below
-
Authors
Moore, Catherine F. https://orcid.org/0000-0003-0198-4788
Weerts, Elise M. https://orcid.org/0000-0002-8234-0919
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (R21DA046154)
- License Information
-
More Information
Article History
Received: 4 August 2025
Accepted: 1 October 2025
First Online: 25 November 2025
Declarations
:
: All procedures used in this study were approved by the Johns Hopkins Institutional Animal Care and Use Committee. The facilities adhered to the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were AAALAC-approved.
: Not applicable.
: Not applicable.
: CM and EW received funds from MyMD Pharmaceuticals, Inc. and MIRA Pharmaceuticals, Inc for contract preclinical research investigating a novel cannabinoid. Neither MyMD nor MIRA had any input regarding the current study. EW received funds from Cultivate Biologics LLC, and Canopy Growth Corp. for clinical research projects unrelated to this paper.
